“We all love to buy pharma stocks when they release positive clinical data, but they can also be solid choices for investors looking for businesses to buy on the dip,” […]
read more3 Biotech/Pharma Stocks With Potential Clinical Trial Catalysts This Quarter
“In light of the ongoing COVID-19 pandemic, a number of pharma companies have postponed new study starts and have paused enrollment/screening in their clinical trials. However, companies that have completed […]
read moreThe Pharmaceutical Companies Experiencing Early Success With These “Miracle” Cancer Drugs
One of the most significant – and relatively recent – innovations in the treatment of cancer are so-called immuno-oncology (IO) drugs. As today’s article explains, these drugs “enlist a patient’s […]
read more20 Biotech And Pharma Stocks Offering More-Than-Your-Average Upside Potential
More than 10 years into this bull market, Buy and Outperform analyst ratings generally come with implied upside potential of 8% to 10%. However, the author of today’s article notes […]
read moreThis Little-Known Biotech Is Attracting The Attention Of Big Pharma – And Creating An Opportunity For Investors
With only 10% of drug candidates that reach the clinical trial stage eventually making their way onto the market, knowing which small biotechs to bet on for big gains is […]
read more